{"id":"W3207977249","doi":"10.2217/fon-2021-0753","title":"Alliance A011801 (compassHER2 RD): Postneoadjuvant T-DM1 + Tucatinib/Placebo in Patients with Residual HER2-Positive Invasive Breast Cancer","year":2021,"lang":"en","type":"article","venue":"Future Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Internal medicine; Breast cancer; Oncology; Placebo; Randomized controlled trial; Cancer; Pathology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003961391,0.0003708563,0.0008729729,0.0001436392,0.0001073083,0.00002994226,0.0002772507,0.0004261291,0.002357787],"category_scores_gemma":[0.0001818849,0.0003087424,0.00007709822,0.0007468939,0.0002724701,0.0001193138,0.0001803496,0.001245819,0.0001470267],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001977684,"about_ca_system_score_gemma":0.00500587,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008689594,"about_ca_topic_score_gemma":0.01489098,"domain_scores_codex":[0.9963145,0.0006394681,0.0004947261,0.0008863491,0.0007588301,0.0009061038],"domain_scores_gemma":[0.9973831,0.0004071369,0.0001929268,0.000608436,0.001020075,0.0003883843],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01025919,0.002469817,0.8467549,0.0003666962,0.0004040753,0.003564176,0.002863178,0.00003807422,0.001006007,0.0002004774,0.08439041,0.04768297],"study_design_scores_gemma":[0.01007076,0.001866575,0.9242729,0.000782846,0.00008981108,0.000303149,0.001319563,0.00000721762,0.001663201,0.00002130702,0.05924932,0.0003533717],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9111881,0.00193061,0.000007266065,0.07021521,0.001199087,0.001741974,0.0004743284,0.00007339235,0.01317007],"genre_scores_gemma":[0.9823472,0.001014159,0.002266835,0.007310797,0.002686844,0.0006552591,0.0005041093,0.0001502564,0.00306455],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07751795,"threshold_uncertainty_score":0.9999365,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01568102170165933,"score_gpt":0.3375341293603767,"score_spread":0.3218531076587174,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}